| 7105- | GEN, | Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer |
| - | Trial, | Pca, | NA |
| - | Trial, | Pca, | NA |
| 7103- | GEN, | A Comprehensive Review of Genistein's Effects in Preclinical Models of Cervical Cancer |
| - | Review, | Cerv, | NA |
| 7102- | GEN, | Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits |
| - | Review, | Var, | NA |
| 2998- | GEN, | Cellular and Molecular Mechanisms Modulated by Genistein in Cancer |
| - | Review, | Var, | NA |
| 2997- | GEN, | Genistein Inhibition of Topoisomerase IIα Expression Participated by Sp1 and Sp3 in HeLa Cell |
| - | in-vitro, | Cerv, | HeLa |
| 1504- | GEN, | Epigenetic targets of bioactive dietary components for cancer prevention and therapy |
| - | Review, | NA, | NA |
| 1435- | GEN, | SFN, | The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 |
| 28- | GEN, | Genistein decreases the breast cancer stem-like cell population through Hedgehog pathway |
| - | in-vivo, | BC, | MCF7 |
| 29- | GEN, | Genistein inhibits the stemness properties of prostate cancer cells through targeting Hedgehog-Gli1 pathway |
| - | in-vivo, | Pca, | 22Rv1 | - | in-vivo, | Pca, | DU145 |
| 166- | GEN, | EGCG, | RES, | CUR, | Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer |
| - | in-vivo, | Pca, | NA |
| 927- | GEN, | PacT, | Bioenhancers from mother nature and their applicability in modern medicine |
| - | Review, | Nor, | NA |
| 4664- | GEN, | CUR, | RES, | EGCG, | SFN | Targeting cancer stem cells by nutraceuticals for cancer therapy |
| - | Review, | Var, | NA |
| 7118- | GEO2, | Germanium oxide inhibits the transition from G2 to M phase of CHO cells |
| - | in-vitro, | Ovarian, | NA |
| 7112- | GEO2, | Hazard assessment of germanium supplements |
| - | Review, | Var, | NA |
| 7113- | GEO2, | Nephrotoxicity and neurotoxicity in humans from organogermanium compounds and germanium dioxide |
| - | Review, | Nor, | NA |
| 7116- | GEO2, | Analytical product study of germanium-containing medicine by different ICP-MS applications |
| - | Study, | Nor, | NA |
| 7119- | GEO2, | Germanium oxide enhances the radiosensitivity of cells |
| - | in-vitro, | Nor, | CHO K1 |
| 7120- | GEO2, | Germanium dioxide-induced nephropathy: a new type of renal disease |
| - | Human, | Var, | NA |
| 7121- | GEO2, | Subacute nephrotoxicity of germanium dioxide in the experimental animal |
| - | in-vivo, | Nor, | NA |
| 7122- | GEO2, | Nephrotoxicity of germanium compounds: report of a case and review of the literature |
| - | Case Report, | Var, | NA |
| 7123- | GEO2, | Kinetics of germanium dioxide in rats |
| - | in-vivo, | Nor, | NA |
| 6566- | Ger, | 5-FU, | Geraniol, a Component of Plant Essential Oils, Sensitizes Human Colonic Cancer Cells to 5-Fluorouracil Treatment |
| - | in-vitro, | CRC, | NA |
| 6572- | Ger, | Pharmacokinetics of Geraniol and Its Metabolites in Mice After Oral Administration |
| - | in-vivo, | Nor, | NA |
| 6562- | Ger, | Potential Effects of Geraniol on Cancer and Inflammation-Related Diseases: A Review of the Recent Research Findings |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 6563- | Ger, | 5-FU, | Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts |
| - | vitro+vivo, | Colon, | SW-620 | - | in-vitro, | Colon, | Caco-2 |
| 6564- | Ger, | Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2 |
| - | in-vitro, | HCC, | HepG2 |
| 6565- | Ger, | Geraniol and geranyl acetate induce potent anticancer effects in colon cancer Colo-205 cells by inducing apoptosis, DNA damage and cell cycle arrest |
| - | in-vitro, | CRC, | COLO205 |
| 6567- | Ger, | Geraniin inhibits proliferation and induces apoptosis through inhibition of phosphatidylinositol 3-kinase/Akt pathway in human colorectal cancer in vitro and in vivo |
| - | vitro+vivo, | CRC, | SW480 | - | in-vitro, | CRC, | HT29 |
| 6568- | Ger, | Perturbation by geraniol of cell membrane permeability and signal transduction pathways in human colon cancer cells |
| - | in-vitro, | Colon, | Caco-2 |
| 6569- | Ger, | Geraniol inhibits cell growth and promotes caspase-dependent apoptosis in nasopharyngeal cancer C666-1 cells via inhibiting PI3K/Akt/mTOR signaling pathway |
| - | in-vitro, | NPC, | C666-1 |
| 6570- | Ger, | Apoptosis-Mediated Anticancer Activity of Geraniol Inhibits NF-κB, MAPK, and JAK-STAT-3 Signaling Pathways in Human Thyroid Cancer Cells |
| - | in-vitro, | Thyroid, | TPC-1 |
| 6571- | Ger, | Unlocking the therapeutic potential of Geraniol: an alternative perspective for metabolic disease management |
| - | Review, | Obesity, | NA |
| 6573- | Ger, | Systematic elucidation of the mechanism of geraniol via network pharmacology |
| - | Study, | Nor, | NA | - | Study, | Var, | NA |
| 7115- | GeS, | A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study |
| - | Trial, | lymphoma, | NA |
| 7114- | GeS, | A phase II study of spirogermanium in advanced human malignancy |
| - | Human, | Var, | NA |
| 7201- | GGB, | Ginkgolide B Inhibits EMT and Promotes Pyroptosis in Gastric Cancer via AKT/mTOR Pathway |
| - | vitro+vivo, | GC, | AGS | - | in-vitro, | GC, | HGC27 |
| 7199- | GGB, | Ginkgolide B Promotes Angiogenesis After Oxygen-Glucose Deprivation by Regulating AKT1 in bEnd.3 Cells |
| - | in-vitro, | Stroke, | NA |
| 7268- | GGB, | Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42 |
| - | in-vitro, | AD, | NA |
| 7269- | GGB, | Ginkgolide B inactivates the NLRP3 inflammasome by promoting autophagic degradation to improve learning and memory impairment in Alzheimer's disease |
| - | in-vivo, | AD, | NA |
| 7270- | GGB, | Ginkgolide B protects hippocampal neurons from apoptosis induced by beta-amyloid 25-35 partly via up-regulation of brain-derived neurotrophic factor |
| - | NA, | AD, | NA |
| 7271- | GGB, | Ginkgolide B Regulates CDDP Chemoresistance in Oral Cancer via the Platelet-Activating Factor Receptor Pathway |
| - | in-vitro, | Oral, | NA |
| 7272- | GGB, | Ginkgolide B Inhibits Human Bladder Cancer Cell Migration and Invasion Through MicroRNA-223-3p |
| - | in-vitro, | Bladder, | NA |
| 7273- | GGB, | Platelet-activating factor induces the stemness of ovarian cancer cells via the PAF/PAFR signaling pathway |
| - | vitro+vivo, | Ovarian, | NA |
| 7274- | GGB, | The potential immunotherapy effect of Ginkgolide B thwarts oral squamous cell carcinoma progression by targeting the SREBP1/KLK8/CCL22 axis |
| - | vitro+vivo, | Oral, | KYSE-510 | - | in-vitro, | Oral, | TE1 |
| 7275- | GGB, | Protective Effect of Ginkgolide B against Cognitive Impairment in Mice via Regulation of Gut Microbiota |
| - | in-vivo, | AD, | NA |
| 7276- | GGB, | Pharmacokinetics of Ginkgolide B after Oral Administration of Three Different Ginkgolide B Formulations in Beagle Dogs |
| - | in-vivo, | Nor, | NA |
| 7277- | GGB, | Ginkgolide B inhibits hydrogen peroxide-induced apoptosis and attenuates cytotoxicity via activating the PI3K/Akt/mTOR signaling pathway in H9c2 cells |
| - | in-vitro, | Nor, | H9c2 |
| 7278- | GGB, | Ginkgolide B: mechanisms of neurobiological effects, prospects for use in the therapy of Alzheimer's disease |
| - | Review, | AD, | NA |
| 7279- | GGB, | Rad, | Radioprotective effect of Ginkgolide B on brain: the mediating role of DCC/MST1 signaling |
| - | in-vivo, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid